Home > Quotes > ACRX
ACRX

AcelRx Pharmaceuticals, Inc. Common Stock Quote & Summary Data

$3.38
*  
0.06
1.81%
Get ACRX Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading ACRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

AcelRx Pharmaceuticals, Inc. Common Stock Intraday Chart




Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 3.40 $ 5.88
Low $ 3.2681 $ 2.59

The current last sale of $3.38 is 30.50% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

We are a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain. Our lead product candidates, ARX-04 and Zalviso, utilize sublingual sufentanil, delivered via a non-invasive route of administration. We intend to commercialize our product candidates in the United States and license the development and commercialization rights to our product candidates for sale outside of the United States through strategic partnerships and collaborations. We may also consider the option to enter into strategic partnerships for our product candidates in the United States. We have chosen sufentanil as the therapeutic ingredient for all of our product candidates. Opioids have been utilized for pain relief for centuries and are the standard of care for the treatment of moderate-to-severe acute pain.  ... More ...  

Risk Grade

Where does ACRX fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?